I agree that this site is using cookies. You can find further informations here.
X
Kukreti, Vishal
86  results:
Search for persons X
?
1

Canadian cancer trials group LY.17: A randomized phase II s..:

Stewart, Douglas A. ; Kuruvilla, John ; Lee, David...
British Journal of Haematology.  , 2024
Link: https://doi.org/10.1111/..
 
?
2

The Impact of CD34+ Cell Collection Yields for Autologous T..:

Lebel, Eyal ; Lajkosz, Katherine ; Masih-Khan, Esther...
Clinical Lymphoma Myeloma and Leukemia.  23 (2023)  11 - p. 850-856 , 2023
Link: https://doi.org/10.1016/..
 
?
3

Impact of a Training Program on Oncology Nurses' Confidence..:

Howell, Doris ; McGowan, Patrick ; Bryant-Lukosius, Denise...
Cancers.  15 (2023)  6 - p. 1811 , 2023
Link: https://doi.org/10.3390/..
 
?
4

Very late relapse in Hodgkin lymphoma: Characterizing an un..:

Cherniawsky, Hannah ; Ting, Esther ; Zhang, Jasper Zhongyuan...
Clinical Lymphoma Myeloma and Leukemia.  23 (2023)  11 - p. 838-843 , 2023
Link: https://doi.org/10.1016/..
 
?
5

Post Salvage Therapy Autologous Transplant for Relapsed Mye..:

Khan, Sahar ; Reece, Donna ; Atenafu, Eshetu G....
Clinical Lymphoma Myeloma and Leukemia.  23 (2023)  2 - p. e97-e106 , 2023
Link: https://doi.org/10.1016/..
 
?
6

Survivorship care for patients curatively treated for Hodgk..:

Powis, Melanie ; Hack, Saidah ; Fazelzad, Rouhi..
Journal of Cancer Survivorship.  , 2023
Link: https://doi.org/10.1007/..
 
?
7

A Phase II, Open-Label Study of an Accelerated Infusion Rat..:

Stakiw, Julie ; Kodad, Shruthi ; LeBlanc, Richard...
Clinical Lymphoma Myeloma and Leukemia.  23 (2023)  7 - p. 484-490 , 2023
Link: https://doi.org/10.1016/..
 
?
8

Implementation of medication reconciliation in outpatient c..:

Powis, Melanie ; Dara, Celina ; Macedo, Alyssa...
BMJ Open Quality.  12 (2023)  2 - p. e002211 , 2023
Link: https://doi.org/10.1136/..
 
?
9

Clinical significance of clonal hematopoiesis in the settin..:

Lackraj, Tracy ; Ben Barouch, Sharon ; Medeiros, Jessie J. F....
American Journal of Hematology.  97 (2022)  12 - p. 1538-1547 , 2022
Link: https://doi.org/10.1002/..
 
?
10

Risk stratification for relapsed/refractory classical Hodgk..:

Yhim, Ho‐Young ; Eshet, Yael ; Metser, Ur...
American Journal of Hematology.  97 (2022)  5 - p. 583-591 , 2022
Link: https://doi.org/10.1002/..
 
?
11

Predicting the Risks of Aggressive-Intent Chemotherapy Toxi..:

Dhir, Vinita ; Maganti, Manjula ; Rozenberg, Dmitry...
Clinical Lymphoma Myeloma and Leukemia.  22 (2022)  8 - p. e792-e803 , 2022
Link: https://doi.org/10.1016/..
 
?
12

Light Chain Amyloidosis (AL) Associated With B Cell Lymphom..:

la Torre, Alfredo De ; Reece, Donna ; Crump, Michael...
Clinical Lymphoma Myeloma and Leukemia.  21 (2021)  12 - p. e946-e959 , 2021
Link: https://doi.org/10.1016/..
 
?
13

Kinetics of response to first‐ and second‐line therapies in..:

Lebel, Eyal ; Li, Xuan ; Paul, Harminder...
European Journal of Haematology.  108 (2021)  3 - p. 204-211 , 2021
Link: https://doi.org/10.1111/..
 
?
14

A descriptive cost‐analysis of MYX.1/MCRN003, a phase 2 cli..:

Monteith, Bethany E. ; Venner, Christopher P. ; Cheung, Matthew C....
European Journal of Haematology.  107 (2021)  3 - p. 333-342 , 2021
Link: https://doi.org/10.1111/..
 
?
15

The impact of lenalidomide maintenance on second‐line chemo..:

Cherniawsky, Hannah M. ; Kukreti, Vishal ; Reece, Donna...
European Journal of Haematology.  106 (2021)  5 - p. 673-681 , 2021
Link: https://doi.org/10.1111/..
 
1-15